Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
 Latest Headlines
Carter County man had a brain tumor removed by Ben Carson
Mon, 30 Nov 2015 03:43:24 GMT (WSAZ)
Doctors Go To Biopsy Baby's Fatal Brain Tumor. They Can't Believe What They See.
Sun, 29 Nov 2015 22:02:21 GMT (IJ Review)
Baby Kissed by Pope Sees Brain Tumor Shrink, Family Says
Thu, 26 Nov 2015 11:36:27 GMT (
Baby's brain tumor shrinks after kiss from Pope Francis
Mon, 23 Nov 2015 23:04:59 GMT (New York Post)
#ChadTough: Michigan boy battling inoperable brain tumor dies
Mon, 23 Nov 2015 21:23:10 GMT (Fox News)
Baby's Tumor Shrinks After Pope's Kiss, Family Says
Sun, 29 Nov 2015 16:09:00 GMT (Headlines & Global News)
Robot protects 8-year-old with brain tumor from deadly infection
Thu, 26 Nov 2015 18:00:00 GMT (
3D Printers Help Create 3D Models of Brain Tumors
Mon, 30 Nov 2015 13:02:19 GMT (HIT Consultant)
Man with brain tumor thankful to be alive
Thu, 26 Nov 2015 16:54:23 GMT (WDIV Detroit)
Baby's Brain Tumor Shrinks After Kiss From Pope
Sat, 21 Nov 2015 03:21:18 GMT (CBS Local)

* Headlines are from industry sponsored news wires, medical journals and established news organizations from around the world . Please consider the source of the content when viewing the story.
Dani Saleh Brain Cancer Research Fund at UCLA

The Dani Saleh Brain Cancer Research Fund supports the brain cancer research collaboration between Dr. Timothy Cloughesy and Dr. Stan Nelson. This fund will directly support the work and training of a research fellow in Dr. Stan Nelson’s lab.

Dr. Nelson is Professor and Vice Chair of Human Genetics and Professor of Psychiatry at the David Geffen School of Medicine at UCLA.

UCLA Neuro-Oncology & SiliconMED Launch Online Tool Correlating Gene Expression Levels with Overall Survival of Brain Cancer Patients

Genomic analysis is a powerful new tool permitting unprecedented insights into how brain tumors form and has been enabled primarily through microarray technology., a new web based tool, is aiming to help clinicians and researchers take the massive amount of data created by microarrays and better visualize gene expression levels and how they relate to the overall survival of brain cancer patients.

Most Popular
. Clinical Trials
. Probe Set Analyzer
. Our Team
. Brain Tumor Translational Resource
. Art of the Brain
. Personalized Medicine using Targeted Molecular Therapy
. Online Giving
. How our Glioblastoma Multiforme Patients Perform
Neuro-Oncology on Facebook

Spring/Summer 2014
UCLA Neuro-Oncology : Breakthroughs Spotlighting new discovery in brain cancer research.

It is time to include patients with brain tumors in phase I trials in oncology.
J Clin Oncol.

Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.
Neuro Oncol.

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma.
Neuro Oncol.

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.
J Neurooncol.

Phase II study of aflibercept in recurrent malignant glioma: a north american brain tumor consortium study.
J Clin Oncol.

All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2015 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2015 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:11/30/2015 8:23:02 AM PST]